PathVysion® HER-2 DNA Probe Kit
Company
Abbott Molecular Inc.
Use
Prognosis of breast cancer (in conjunction with other clinical data)
Features
First NIH licensed technology in an FDA approved product to be used in personalized medicine
NIH Contribution
Connection of HER2 gene with breast cancer.
Approval Type
FDA
HHS Institute/Agency
NCI
Inventor(s)
C. King
Year
1998
Tech Cat
Diagnostic
Request More Info
